Tatva Chintan Updates Investor Presentation Following Metric Corrections
Tatva Chintan Pharma Chem Ltd · Investor Presentation · 20 Oct 2026, 2:46 am
Tatva Chintan Updates Investor Presentation Following Metric Corrections Tatva Chintan Pharma Chem Limited released an updated investor presentation on 19th Oct'26, rectifying typographical errors on page 12 for H1FY27 metrics: RoE is corrected to 6.3% (previously 2.6%) and annualized Debt-to-EBITDA is adjusted to 1.16x (previously 4.30x). All other financial figures remain unchanged. In Q2FY27, revenue from operations grew 76% YoY (30% QoQ) to ₹2,173 Mn, EBITDA reached ₹407 Mn (up 83% YoY), and PAT surged 116% YoY to ₹215 Mn, despite temporary headwinds from elevated solvent prices and freight costs.
Original exchange filing (PDF)
More announcements from Tatva Chintan Pharma Chem Ltd
- Investor Presentation for the quarter and half year ended 30 September 2026. · 19 Oct 2026
- Earnings Call scheduled to be held on Monday, 19 October 2026 at 05:00 p.m. (IST) has been cancelled due to unforeseen circumstances. · 19 Oct 2026
- Outcome Of the Board Meeting Held On 19.10.2026 · 19 Oct 2026
- Enclosed · 19 Oct 2026
- Tatva Chintan Pharma Chem Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 19 Oct 2026
- Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. · 16 Oct 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of .... · 19 Oct 2026
- TATVA CHINTAN PHARMA CHEM LIMITED has informed the Exchange about Board Meeting to be held on 19-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 19 Oct 2026
